Follow
William Grant Dunn
William Grant Dunn
Clinical Research Fellow, University of Cambridge
Verified email at cam.ac.uk
Title
Cited by
Cited by
Year
Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: A systematic review and meta-analyses
S Al AlShaikh, T Quinn, W Dunn, M Walters, J Dawson
European stroke journal 1 (2), 65-75, 2016
1112016
Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial
CN Harrison, J Nangalia, R Boucher, A Jackson, C Yap, J O'Sullivan, ...
Journal of Clinical Oncology 41 (19), 3534-3544, 2023
952023
Multiparameter prediction of myeloid neoplasia risk
M Gu, SC Kovilakam, WG Dunn, L Marando, C Barcena, I Mohorianu, ...
Nature genetics 55 (9), 1523-1530, 2023
522023
Diverse roles for T-bet in the effector responses required for resistance to infection
G Harms Pritchard, AOH Hall, DA Christian, S Wagage, Q Fang, ...
The Journal of Immunology 194 (3), 1131-1140, 2015
522015
Multimodal interventions to enhance adherence to secondary preventive medication after stroke: a systematic review and meta‐analyses
S Al AlShaikh, T Quinn, W Dunn, M Walters, J Dawson
Cardiovascular therapeutics 34 (2), 85-93, 2016
272016
Prevalence and significance of DDX41 gene variants in the general population
S Cheloor Kovilakam, M Gu, WG Dunn, L Marando, C Barcena, ...
Blood 142 (14), 1185-1192, 2023
242023
In patients with a tumour invading the phrenic nerve does prophylactic diaphragm plication improve postoperative lung function?
GW Beattie, WG Dunn, M Asif
Interactive cardiovascular and thoracic surgery 23 (3), 454-458, 2016
112016
Computational analysis of peripheral blood smears detects disease-associated cytomorphologies
JG de Almeida, E Gudgin, M Besser, WG Dunn, J Cooper, T Haferlach, ...
Nature Communications 14 (1), 4378, 2023
92023
Ruxolitinib versus best available therapy for PV intolerant or resistant to hydroxycarbamide in a randomized trial
C Harrison, J Nangalia, RH Boucher, A Jackson, C Yap, J O'Sullivan, ...
Blood 140 (Supplement 1), 1781-1783, 2022
62022
Clonal hematopoiesis and hematological malignancy
WG Dunn, MA McLoughlin, GS Vassiliou
The Journal of Clinical Investigation 134 (19), 2024
42024
S121: MULTIPARAMETER PREDICTION OF MYELOID NEOPLASIA RISK
M Gu, SC Kovilakam, W Dunn, L Marando, C Barcena, I Mohorianu, S Kar, ...
HemaSphere 7 (Suppl), e53186b7, 2023
12023
Author Correction: Multiparameter prediction of myeloid neoplasia risk
M Gu, SC Kovilakam, WG Dunn, L Marando, C Barcena, I Mohorianu, ...
Nature Genetics 55 (10), 1777, 2023
12023
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
WG Dunn, MS Gu, MA Fabre, J Cooper, JF Nomdedeu, L Koumas, ...
Annals of Hematology, 1-3, 2022
12022
A randomised crossover trial of the acute effects of a deep-fried Mars bar or porridge on the cerebral vasculature
WG Dunn, MR Walters
Scottish Medical Journal 59 (4), 182-187, 2014
12014
Prevalence and Significance of Clonal Monocytosis of Undetermined Significance (CMUS) Amongst 431,531 United Kingdom Biobank Participants
WG Dunn, M Gu, P Quiros, I Mohorianu, DH Wiseman, GS Vassiliou
Blood 144, 4048, 2024
2024
Machine learning framework for predicting the presence of high-risk clonal haematopoiesis using complete blood count data: a population-based study of 431,531 UK Biobank …
WG Dunn, I Withnell, M Gu, P Quiros, S Cheloor Kovilakam, L Marando, ...
medRxiv, 2024.09. 30.24314606, 2024
2024
Machine Learning for Identification of High-Risk Clonal Haematopoiesis Using Blood Count Data
WG Dunn, I Withnell, M Gu, P Quiros, SC Kovilakam, L Marando, M Fabre, ...
Blood 142, 1318, 2023
2023
P442: DDX41 GERMLINE VARIANTS: POPULATION PREVALENCE, SIGNIFICANCE AND LEUKEMIC EVOLUTION
SC Kovilakam, M Gu, WG Dunn, L Marando, C Barcena, SN Zainal, ...
HemaSphere 7 (S3), e363625f, 2023
2023
S125 PATHWAY AND GENE SET OVERDISPERSION ANALYSIS OF SINGLE CELL TRANSCRIPTOMIC DATA FROM PATIENTS WITH CHRONIC MYELOID LEUKAEMIA HIGHLIGHTS TRANSCRIPTIONAL HETEROGENEITY IN …
W Dunn, L Hopcroft
HemaSphere 3, 14-15, 2019
2019
Interventions to Enhance Adherence to Secondary Preventative Medication After Stroke a Systematic Review and Meta-Analysis
S Al AlShaikh, T Quinn, W Dunn, J Dawson
STROKE 47, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20